Report Subject - Medical Affairs - Page 1

Learn More Trends in Digital Pharma Marketing (2020)

How has COVID-19 impacted pharma digital marketing activity—now and for the future? The effects of coronavirus on pharma marketing budgets, priorities and actions cannot be ignored. During the pandemic, pharma...

Compare
Learn More Digital Biomarkers: Pharma’s clinical development future?

Assessing digital biomarker applications that could radically impact pharma's clinical research practice By precisely and continuously measuring disease symptoms, digital biomarkers can allow pharma to establish valid...

Compare
Learn More The MSL Technology Survey (2020)

With physical distancing currently the norm, MSLs must radically change their working practice to effectively engage with KOLs Face-to-face meetings are the preferred choice of MSLs when sharing key scientific...

Compare
Learn More Injectables and Implantables

Injectables and implantables are key to advancing patient centricity and adherence The development of controlled and prolonged release injectable and implantable drugs has seen huge leaps forward in recent years...

Compare
Learn More The Digitisation of Diabetes: Opportunities and Challenges for Industry

Assessing the revolutionary impact of digital technologies on the management of diabetes Advanced digital technologies and devices are driving fundamental change in the management of both Type 1 and 2...

Compare
Learn More AI in Medical Diagnostics

Evaluating the potential of artificial intelligence to revolutionise and expand medical diagnostics Artificial intelligence (AI) driven technologies have already radically changed practice and outcomes in medical...

Compare
Learn More Health Insurance Disruptors: Going Digital

Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...

Compare
Learn More Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)

Drug innovation is delivering highly-effective medicines that significantly improve patient outcomes and, in some cases, are curative of disease. Yet of the 55 medicines that were approved in the US between January 2018...

Compare
Learn More Interoperability in Health

Experts agree interoperability will unlock considerable value across healthcare Interoperability—enabling information systems to share data—offers a wealth of opportunities for multiple health stakeholders,...

Compare
Learn More Pricing Transparency in Pharma

Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...

Compare
Learn More Regulating Digital Health

As digital health progressively enters mainstream therapy, how should it be regulated and to what outcome? Digital health is booming and as investment in digital health technology grows more products and services will...

Compare
Learn More The Future of Disease Interception

What does pharma need to do to develop this radical health model of the future? Disease interception is a novel healthcare model that identifies, treats and sometimes cures disease before it is fully manifested. There...

Compare
Learn More The Future of Personalised Medicine: The Role of Simulation and Digital Twins

Beyond the hype, where might simulation and digital twin technology deliver value for pharma? There is considerable excitement about the potential for simulation and digital twin technology to drive the personalised...

Compare
Learn More The Future of Virtual Healthcare

What strategy should pharma be pursuing in virtual healthcare? Applications for virtual healthcare engagement are quickly evolving beyond websites and apps towards advanced tools such as virtual assistants and virtual...

Compare
Learn More The Impact of 5G on Healthcare

Health insurance: how to thrive in an increasingly digital health world 5G wireless network technology has the potential to revolutionize pharma's business. Combined with advances in artificial intelligence and machine...

Compare
Learn More Financing High-Cost Therapies through Reinsurance

Could reinsurance allay health insurers' fear about high cell and gene therapy costs? With the prospect of many cell and gene therapies coming to market in the medium term, often with record breaking list prices and...

Compare
Learn More The Impact of Drug Compounding on Pharma

Drug compounding meets unmet clinical needs, widens therapy choice and expands patient access to medicines. What are the lessons and opportunities for pharma? Drug compounding is a fast growing sector meeting the needs...

Compare
Learn More The Future of CRISPR

Where will CRISPR deliver real value? Investors and pharma are enthusiastic about CRISPR gene editing technology: not only can it be used to develop new therapeutics, it has become a powerful tool in drug discovery,...

Compare
Learn More Virtual Clinical Trials: The future of drug development?

How viable are virtual clinical trials as a model for conducting clinical research? With our deepening understanding of disease and ever more targeted therapies, slow and costly traditional clinical trials alone are no...

Compare
Learn More Medical-grade Wearable Technology: Applications and implications for pharma

Leveraging clinical wearables and digiceuticals to gain competitive advantage From smart wristbands and glasses to tiny sensors in pills, the latest advances in medical-grade technology are unlocking new opportunities...

Compare

Browse by

FirstWord Medical Affairs Reports